Proteolysis targeting chimeric (PROTAC) technology is a recently discovered technique that has profound efficacy in cancer. This approach was first…
In recent years, many pharmaceutical companies have chosen to reduce their R&D investment in chemistry, viewing synthetic chemistry more as…
Most Preclinical CROs provide studies that aim at providing information about safety and efficacy of a drug candidate before testing…
Discovering and developing a new therapeutic can take 10-15 years, on average, with costs often exceeding $1 billion. For every…